Department of Internal Medicine, National Taiwan University Hospital Bei-Hu Branch, National Taiwan University College of Medicine, Taipei, Taiwan; Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei, Taiwan.
Department of Internal Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan.
Clin Gastroenterol Hepatol. 2017 Nov;15(11):1768-1775. doi: 10.1016/j.cgh.2017.05.049. Epub 2017 Jun 8.
BACKGROUND & AIMS: Endoscopic papillary balloon dilation (EPBD) is an alternative to endoscopic sphincterotomy for choledocholithiasis. Unlike endoscopic sphincterotomy, EPBD preserves biliary sphincter function, reducing long-term risk of recurrent choledocholithiasis by 50%. Guidelines recommend that duration of EPBD exceeds 2 minutes, to adequately loosen the sphincter and reduce risks of failed stone extraction and post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis. However, it is unclear whether this long duration of EPBD impairs sphincter function and negates the long-term benefit of EPBD. We performed a randomized controlled trial to determine whether long-duration (>1 minute) EPBD increases the risk of subsequent choledocholithiasis and hepatobiliary complications compared with short-duration EPBD (<1 minute).
We performed a prospective study of 170 adult patients who underwent ERCP for suspected choledocholithiasis from April 2007 through October 2008 at 2 centers in Taiwan. Patients were randomly assigned to groups that underwent 1-minute (n = 86) or 5-minute (n = 84) EPBD for choledocholithiasis; patients were followed through June 2015. One month after the initial ERCP, patients were examined and liver function tests and abdominal sonographies were performed. Patients were then examined every 3-6 months over a median follow-up period of approximately 7 years. The primary outcome was recurrent choledocholithiasis or acute cholangitis and the secondary outcome was overall hepatobiliary complications. We assessed the effects of EPBD duration by Cox regression.
Thirteen patients (15.1%) developed recurrent choledocholithiasis or acute cholangitis after 1-minute EPBD, and 10 patients (11.9%) developed recurrent choledocholithiasis or acute cholangitis after 5-minute EPBD (P = .352). There was no significant difference between groups in number of hepatobiliary complications (P = .154). Compared with 1-minute EPBD, 5-minute EPBD did not increase risk of the primary outcome (adjusted hazard ratio, 0.76; 95% confidence interval, 0.32-1.82) or the secondary outcome (adjusted hazard ratio, 0.65; 95% confidence interval, 0.31-1.40). Mechanical lithotripsy, performed for failed stone extraction with EPBD at initial ERCP, was a risk factor for primary and secondary outcomes.
In a randomized controlled trial, we found that the risk of recurrent choledocholithiasis and hepatobiliary complications did not increase with long-duration EPBD (>1 minute), but was increased with mechanical lithotripsy.
内镜下乳头球囊扩张术(EPBD)是治疗胆总管结石的内镜下括约肌切开术的替代方法。与内镜下括约肌切开术不同,EPBD 保留了胆道括约肌功能,将复发性胆总管结石的长期风险降低了 50%。指南建议 EPBD 持续时间超过 2 分钟,以充分松解括约肌并降低碎石提取失败和内镜逆行胰胆管造影(ERCP)后胰腺炎的风险。然而,目前尚不清楚这种长时间的 EPBD 是否会损害括约肌功能,并否定 EPBD 的长期益处。我们进行了一项随机对照试验,以确定与短时间 EPBD(<1 分钟)相比,长时间(>1 分钟)EPBD 是否会增加随后发生的胆总管结石和肝胆并发症的风险。
我们对 2007 年 4 月至 2008 年 10 月在台湾的 2 个中心接受 ERCP 治疗疑似胆总管结石的 170 例成年患者进行了前瞻性研究。患者被随机分配至 1 分钟(n=86)或 5 分钟(n=84)EPBD 组治疗胆总管结石;患者随访至 2015 年 6 月。初次 ERCP 后 1 个月,对患者进行检查,并进行肝功能检查和腹部超声检查。然后,在大约 7 年的中位随访期间,每 3-6 个月对患者进行检查。主要结局是复发性胆总管结石或急性胆管炎,次要结局是总体肝胆并发症。我们通过 Cox 回归评估 EPBD 持续时间的影响。
1 分钟 EPBD 后,13 例(15.1%)患者发生复发性胆总管结石或急性胆管炎,5 分钟 EPBD 后 10 例(11.9%)患者发生复发性胆总管结石或急性胆管炎(P=0.352)。两组间肝胆并发症的数量无显著差异(P=0.154)。与 1 分钟 EPBD 相比,5 分钟 EPBD 并未增加主要结局(调整后的危险比,0.76;95%置信区间,0.32-1.82)或次要结局(调整后的危险比,0.65;95%置信区间,0.31-1.40)的风险。初次 ERCP 时,EPBD 碎石提取失败后进行机械碎石术是主要和次要结局的危险因素。
在一项随机对照试验中,我们发现长时间 EPBD(>1 分钟)并不会增加复发性胆总管结石和肝胆并发症的风险,但会增加机械碎石术的风险。